InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.360
+0.040 (1.72%)
At close: Sep 17, 2025, 4:00 PM EDT
2.380
+0.020 (0.85%)
After-hours: Sep 17, 2025, 5:02 PM EDT
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $4.73 million as of September 17, 2025. Its market cap has increased by 62.94% in one year.
Market Cap
4.73M
Enterprise Value
893.39K
1-Year Change
62.94%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $4.73M, a decrease of -81.83%. That is a compound annual growth rate of -29.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.80M | -17.65% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
| Nov 16, 2020 | 26.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |